BE1002295A5 - Medicaments. - Google Patents
Medicaments. Download PDFInfo
- Publication number
- BE1002295A5 BE1002295A5 BE8900740A BE8900740A BE1002295A5 BE 1002295 A5 BE1002295 A5 BE 1002295A5 BE 8900740 A BE8900740 A BE 8900740A BE 8900740 A BE8900740 A BE 8900740A BE 1002295 A5 BE1002295 A5 BE 1002295A5
- Authority
- BE
- Belgium
- Prior art keywords
- methyl
- drugs
- cylco
- carbazol
- piroxicam
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 abstract 1
- 229940121708 Oxygenase inhibitor Drugs 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- AMLYRCOEFHJSFS-UHFFFAOYSA-N carbazol-1-one Chemical compound C1=CC=C2C3=CC=CC(=O)C3=NC2=C1 AMLYRCOEFHJSFS-UHFFFAOYSA-N 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- 239000003650 oxygenase inhibitor Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229960002702 piroxicam Drugs 0.000 abstract 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888816187A GB8816187D0 (en) | 1988-07-07 | 1988-07-07 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE1002295A5 true BE1002295A5 (fr) | 1990-11-20 |
Family
ID=10640032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE8900740A BE1002295A5 (fr) | 1988-07-07 | 1989-07-06 | Medicaments. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4983621A (enExample) |
| JP (1) | JPH0276815A (enExample) |
| AU (1) | AU633496B2 (enExample) |
| BE (1) | BE1002295A5 (enExample) |
| CA (1) | CA1330306C (enExample) |
| CH (1) | CH679553A5 (enExample) |
| DE (1) | DE3922263A1 (enExample) |
| DK (1) | DK336489A (enExample) |
| FR (1) | FR2633831B1 (enExample) |
| GB (2) | GB8816187D0 (enExample) |
| IT (1) | IT1232155B (enExample) |
| NL (1) | NL8901727A (enExample) |
| SE (1) | SE8902458L (enExample) |
| ZA (1) | ZA895142B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000074A1 (en) * | 1991-06-26 | 1993-01-07 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| GB9310756D0 (en) * | 1993-05-25 | 1993-07-14 | Glaxo Lab Sa | Compositions |
| GB9710767D0 (en) * | 1996-06-26 | 1997-07-23 | On Ninh | Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same |
| GB9816899D0 (en) | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
| SK6182003A3 (en) * | 2000-10-30 | 2004-03-02 | Teva Pharma | Crystalline and solvated forms of ondansetrone hydrochloride and preparation thereof |
| ATE364611T1 (de) * | 2002-04-29 | 2007-07-15 | Teva Gyogyszergyar Zartkoeruee | Verfahren zur herstellung von 1,2,3,9-tetrahydro- 9-methyl-3- (2-methyl-1h-imidazol-1-yl)methylö- h-carbazol-4-on |
| US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| AU2003257060A1 (en) * | 2002-07-31 | 2004-02-16 | Sepracor Inc. | Cyclooxygenase-2 inhibitors for appetite suppression |
| WO2008079295A1 (en) * | 2006-12-22 | 2008-07-03 | Novadel Pharma Inc. | Stable anti-nausea oral spray formulations and methods |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2105193A (en) * | 1981-09-04 | 1983-03-23 | Glaxo Group Ltd | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
| EP0272876B1 (en) * | 1986-12-17 | 1993-10-13 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB105193A (en) * | 1916-08-29 | 1917-04-05 | Thomas Joseph Mills | Improvements in Rotary Printing Machines. |
| US4309408A (en) * | 1978-11-16 | 1982-01-05 | Beecham Group Limited | Effervescent powders |
| AU528098B2 (en) * | 1978-11-16 | 1983-04-14 | Beecham Group Plc | Analgesic tablet |
| EP0385517B1 (en) * | 1985-03-14 | 1993-04-14 | BEECHAM GROUP plc | Medicaments for the treatment of emesis |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
-
1988
- 1988-07-07 GB GB888816187A patent/GB8816187D0/en active Pending
-
1989
- 1989-07-06 SE SE8902458A patent/SE8902458L/xx not_active Application Discontinuation
- 1989-07-06 IT IT8948163A patent/IT1232155B/it active
- 1989-07-06 CH CH2511/89A patent/CH679553A5/fr not_active IP Right Cessation
- 1989-07-06 AU AU37904/89A patent/AU633496B2/en not_active Ceased
- 1989-07-06 FR FR8909113A patent/FR2633831B1/fr not_active Expired - Fee Related
- 1989-07-06 BE BE8900740A patent/BE1002295A5/fr not_active IP Right Cessation
- 1989-07-06 GB GB8915499A patent/GB2220352B/en not_active Expired - Fee Related
- 1989-07-06 CA CA000604967A patent/CA1330306C/en not_active Expired - Fee Related
- 1989-07-06 JP JP1175419A patent/JPH0276815A/ja active Pending
- 1989-07-06 DE DE3922263A patent/DE3922263A1/de not_active Withdrawn
- 1989-07-06 ZA ZA895142A patent/ZA895142B/xx unknown
- 1989-07-06 DK DK336489A patent/DK336489A/da not_active Application Discontinuation
- 1989-07-06 NL NL8901727A patent/NL8901727A/nl not_active Application Discontinuation
- 1989-07-06 US US07/375,913 patent/US4983621A/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2105193A (en) * | 1981-09-04 | 1983-03-23 | Glaxo Group Ltd | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
| EP0272876B1 (en) * | 1986-12-17 | 1993-10-13 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
Also Published As
| Publication number | Publication date |
|---|---|
| IT8948163A0 (it) | 1989-07-06 |
| GB2220352A (en) | 1990-01-10 |
| CH679553A5 (enExample) | 1992-03-13 |
| GB8915499D0 (en) | 1989-08-23 |
| DE3922263A1 (de) | 1990-01-11 |
| FR2633831A1 (fr) | 1990-01-12 |
| DK336489D0 (da) | 1989-07-06 |
| DK336489A (da) | 1990-01-08 |
| US4983621A (en) | 1991-01-08 |
| GB8816187D0 (en) | 1988-08-10 |
| CA1330306C (en) | 1994-06-21 |
| NL8901727A (nl) | 1990-02-01 |
| SE8902458D0 (sv) | 1989-07-06 |
| SE8902458L (sv) | 1990-01-08 |
| AU3790489A (en) | 1990-01-11 |
| IT1232155B (it) | 1992-01-25 |
| AU633496B2 (en) | 1993-02-04 |
| JPH0276815A (ja) | 1990-03-16 |
| ZA895142B (en) | 1990-06-27 |
| GB2220352B (en) | 1992-03-18 |
| FR2633831B1 (fr) | 1993-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1002249A4 (fr) | Compositions pharmaceutiques. | |
| IL119627A0 (en) | Controlled-release pharmaceutical preparations | |
| EA200101026A1 (ru) | Предварительно желатинированный крахмал в композиции с контролируемым высвобождением | |
| ES2188782T3 (es) | Formulaciones farmaceuticas que contienen darifenacina. | |
| YU13695A (sh) | Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije | |
| RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
| CA2105180A1 (en) | Compositions containing sumatriptan | |
| EP1365749A4 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| KR880007073A (ko) | 의 약 품 | |
| NO912416D0 (no) | Terapeutisk aktiv benzimidazolforbindelse og fremgangsmaate for dens fremstilling. | |
| EP1027053A4 (en) | METHOD FOR PREVENTING CYCLOSPORINES AND TACROLIMUS TO KIDNEY POISONING | |
| BE1002255A5 (fr) | Medicaments. | |
| SE8902458L (sv) | Laekemedelskomposition | |
| FR2660192B1 (fr) | Formulation liposomiales pour l'administration topique ou vaginale de medicaments. | |
| CA2135179A1 (en) | Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration | |
| BE1002256A3 (fr) | Medicaments. | |
| BE1002182A5 (fr) | Compositions pharmaceutiques. | |
| JPH0314812B2 (enExample) | ||
| GEP20043377B (en) | Pharmaceutical Complex | |
| HUP9901935A2 (hu) | Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet | |
| FR2685204B1 (fr) | Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine. | |
| TH25306A (th) | วิธีของการใช้สำหรับยับยั้งการสูญเสียกระดูกและ?การลดคอเลสเทอรอลในซีรัม | |
| DE69318418D1 (de) | Pharmazeutische zusammensetzungen, die 5-ht 1-rezeptoragonisten und absorptionsverstärker enthalten | |
| CA2336711A1 (en) | Blister containing a transdermal therapeutic system and a single dose form of administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: GLAXO GROUP LTD Effective date: 19950731 |